176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.07%
Negative revenue growth while MU stands at 22.65%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.02%
Negative gross profit growth while MU is at 27.34%. Joel Greenblatt would examine cost competitiveness or demand decline.
-27.22%
Negative EBIT growth while MU is at 38.93%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-27.22%
Negative operating income growth while MU is at 38.93%. Joel Greenblatt would press for urgent turnaround measures.
-16.79%
Negative net income growth while MU stands at 3872.09%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.65%
Negative EPS growth while MU is at 4025.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.66%
Negative diluted EPS growth while MU is at 3675.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.35%
Share reduction while MU is at 0.90%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.09%
Reduced diluted shares while MU is at 7.91%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
148.51%
OCF growth above 1.5x MU's 14.90%. David Dodd would confirm a clear edge in underlying cash generation.
194.77%
FCF growth above 1.5x MU's 3.80%. David Dodd would verify if the firm’s strategic investments yield superior returns.
91.29%
Similar 10Y revenue/share CAGR to MU's 88.70%. Walter Schloss might see both firms benefiting from the same long-term demand.
-17.64%
Negative 5Y CAGR while MU stands at 46.75%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
1.38%
3Y revenue/share CAGR under 50% of MU's 26.11%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
193.99%
10Y OCF/share CAGR at 50-75% of MU's 277.86%. Martin Whitman might fear a structural deficiency in operational efficiency.
59.86%
Below 50% of MU's 120.70%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
486.12%
Positive 3Y OCF/share CAGR while MU is negative. John Neff might see a big short-term edge in operational efficiency.
176.80%
Below 50% of MU's 917.57%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-39.42%
Negative 5Y net income/share CAGR while MU is 471.37%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
19.44%
Below 50% of MU's 452.30%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
319.49%
10Y equity/share CAGR above 1.5x MU's 8.45%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
65.02%
5Y equity/share CAGR above 1.5x MU's 10.68%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
63.01%
3Y equity/share CAGR above 1.5x MU's 26.06%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.09%
AR growth is negative/stable vs. MU's 54.96%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-2.17%
Inventory is declining while MU stands at 52.94%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.55%
Asset growth well under 50% of MU's 36.02%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.58%
BV/share growth of 2.58% while MU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-3.20%
We’re deleveraging while MU stands at 66.58%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
4.87%
R&D dropping or stable vs. MU's 18.14%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.75%
SG&A declining or stable vs. MU's 51.97%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.